A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

CRISPR technology could one day create “designer babies, ” raising major ethical and social inequality concerns.

A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

To add to its globally leading universities, London’s competitive advantages in frontier innovation also include its deep and ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

Tom Brady's dog is a clone of a "beloved" pet that died, the seven-time Super Bowl champion revealed on Tuesday.

Meanwhile, ARK sold 15,362 shares of Roku Inc (NASDAQ:ROKU) through its ARKK ETF, totaling $1,668,774. This marks a continuation of ARK’s recent trend of reducing its holdings in the streaming ...

Smith, a microbiologist whose discovery revolutionize the field of genetic engineering, was a Johns Hopkins School of ...

Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for ...

While some practices remain controversial or speculative, biohackers are united by a shared curiosity: how can we engineer ...